DeNova Research
Chicago, Illinois, 60611, United States
NCT Number: NCT01708928
Up to 30 subjects will be enrolled. All subjects will receive one Ultherapy treatment to the lower two thirds of the face and neck. Subjects will be equally grouped into those with a history of submentoplasty and or rhytidectomy and those naive to submentoplasty and or rhytidectomy. Follow-up visits will occur at 14, 30, 60, 90 and 180 days following treatment. Study images will be obtained pre-treatment, 30-60 minutes post-treatment, and at each follow-up visit.
Looking for future studies?
Notify Me30 year–65 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60611, United States
This is a prospective single center study. Subjects will be enrolled one per group as they present. Efficacy will be determined by the change in submental volume and cervicomental angle. GAIS and patient satisfaction questionnaires will also be obtained.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Focused ultrasound energy delivered below the surface of the skin
Other names: Ultherapy™
Time frame: 90 days post-treatment
Measured by the Canfield Vectra® imaging system comparing pre-treatment baseline photos to post-treatment photos.
Time frame: 90 days post-treatment
Global Aesthetic Improvement Scale (GAIS) and patient satisfaction questionnaires will be obtained.
Ulthera, Inc
Industry
Feasibility Study: Evaluation Of The Ulthera™ System For Obtaining Lift And Tightening Of The Neck Skin In Patients With A History Of Submentoplasty And Or Rhytidectomy Vs Patients Naïve To Submentoplasty Or Rhytidectomy - A Feasibility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06724510
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases
Beijing, China
View Trial DetailsNCT06351358
Body Weight, Body Weight Changes
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06243744
Collagen Degeneration, Collagen Shrinkage
Bradenton, Florida, United States
View Trial DetailsNCT07255560
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases
Valencia, Spain
View Trial Details